Recommend Cancer Biology & Therapy to your librarian for 2008. Download the form here.

Sign up for Table of Contents Alerts.

home subscribe search archive forthcoming

Email this page Print this page

Research Paper

Survivin knockdown combined with apoptin overexpression inhibits cell growth significantly

Qin Liu, Hanjiang Fu, Ruiyun Xing, Yi Tie, Jie Zhu, Zhixian Sun and Xiaofei Zheng

volume 7 | issue 7

July 2008
Pages: 1053 - 1060

Purchase article for $19

Subscribe to this journal for $129/year

The initiation and progression of tumor is regulated by multiple genes. Survivin belongs to the inhibitor of apoptosis protein (IAP) family and is overexpressed in most types of human tumors. Apoptin, originally identified from chicken anemia virus (CAV), can specifically induce apoptosis of human tumor cells rather than normal cells. In this study, survivin expression was silenced by microRNA (miRNA)-mediated RNA interference (RNAi); meanwhile, the engineered miRNA vector was also designed to express apoptin gene. The apoptosis and cell growth were then examined by flow cytometry and MTT assay. The miRNA-mediated knockdown of survivin in combination with apoptin overexpression significantly induced apoptosis and inhibited cell growth. Importantly, the combined strategy was more effective on inducing apoptosis and inhibiting cell growth than either survivin downregulation or apoptin overexpression alone. Taken together, the combined strategy offers potential advantages in control of tumorigenesis, and thus deserves further research as a preferred approach in cancer gene therapy

Authors

Qin Liu

Department of Biochemistry and Molecular Biology, Beijing Institute of Radiation Medicine, Beijing, China

Hanjiang Fu

Department of Biochemistry and Molecular Biology, Beijing Institute of Radiation Medicine, Beijing, China

Ruiyun Xing

Department of Biochemistry and Molecular Biology, Beijing Institute of Radiation Medicine, Beijing, China

Yi Tie

Department of Biochemistry and Molecular Biology, Beijing Institute of Radiation Medicine, Beijing, China

Jie Zhu

Department of Biochemistry and Molecular Biology, Beijing Institute of Radiation Medicine, Beijing, China

Zhixian Sun

Department of Biochemistry and Molecular Biology, Beijing Institute of Radiation Medicine, Beijing, China

Xiaofei Zheng

Department of Biochemistry and Molecular Biology, Beijing Institute of Radiation Medicine, Beijing, China


Purchase article for $19

Subscribe to this journal for $129/year